Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Talbot

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Plos Medicine|February 15, 2017
Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health ServiceAngela Hamblin, Sarah Wordsworth, Jilles M Fermont, et al.
CJEM|April 2, 2023
A value-based comparison of the management of respiratory diseases in walk-in clinics and emergency departmentsTania Marx, Lynne Moore, Denis Talbot, et al.
Future Oncology (London, England)|April 2, 2020
Quality of life with second or third line <i>nab</i>-paclitaxel-based regimens in advanced non-small-cell lung cancerSantiago Ponce Aix, Denis Talbot, Ramaswamy Govindan, et al.
Pharmacoepidemiology and Drug Safety|November 14, 2025
The Reporting and Methodological Recommendations for Observational Studies Estimating the Effects of Deprescribing Medications (REMROSE-D) ISPE-Endorsed GuidanceKaleen N Hayes, Joshua D Niznik, Danijela Gnjidic, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2023
Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure RiskNicholas Brousseau, Sara Carazo, Yossi Febriani, et al.
JACC. Advances|September 20, 2025
Coronary Heart Disease Attributable to Psychosocial Stressors at WorkMathilde Lavigne-Robichaud, Xavier Trudel, Denis Talbot, et al.
American Journal of Epidemiology|November 21, 2024
Evaluation of real-world evidence to assess health outcomes related to deprescribing medications in older adults: an International Society for Pharmacoepidemiology-endorsed systematic review of methodologyKaleen N Hayes, Joshua David Niznik, Danijela Gnjidic, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2022
Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, CanadaDanuta M Skowronski, Yossi Febriani, Manale Ouakki, et al.
JMIR Research Protocols|February 22, 2021
A Value-Based Comparison of the Management of Ambulatory Respiratory Diseases in Walk-in Clinics, Primary Care Practices, and Emergency Departments: Protocol for a Multicenter Prospective Cohort StudySimon Berthelot, Mylaine Breton, Jason Robert Guertin, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Plos Medicine|February 15, 2017
Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health ServiceAngela Hamblin, Sarah Wordsworth, Jilles M Fermont, et al.
CJEM|April 2, 2023
A value-based comparison of the management of respiratory diseases in walk-in clinics and emergency departmentsTania Marx, Lynne Moore, Denis Talbot, et al.
Future Oncology (London, England)|April 2, 2020
Quality of life with second or third line <i>nab</i>-paclitaxel-based regimens in advanced non-small-cell lung cancerSantiago Ponce Aix, Denis Talbot, Ramaswamy Govindan, et al.
Pharmacoepidemiology and Drug Safety|November 14, 2025
The Reporting and Methodological Recommendations for Observational Studies Estimating the Effects of Deprescribing Medications (REMROSE-D) ISPE-Endorsed GuidanceKaleen N Hayes, Joshua D Niznik, Danijela Gnjidic, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2023
Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure RiskNicholas Brousseau, Sara Carazo, Yossi Febriani, et al.
JACC. Advances|September 20, 2025
Coronary Heart Disease Attributable to Psychosocial Stressors at WorkMathilde Lavigne-Robichaud, Xavier Trudel, Denis Talbot, et al.
American Journal of Epidemiology|November 21, 2024
Evaluation of real-world evidence to assess health outcomes related to deprescribing medications in older adults: an International Society for Pharmacoepidemiology-endorsed systematic review of methodologyKaleen N Hayes, Joshua David Niznik, Danijela Gnjidic, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2022
Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, CanadaDanuta M Skowronski, Yossi Febriani, Manale Ouakki, et al.
JMIR Research Protocols|February 22, 2021
A Value-Based Comparison of the Management of Ambulatory Respiratory Diseases in Walk-in Clinics, Primary Care Practices, and Emergency Departments: Protocol for a Multicenter Prospective Cohort StudySimon Berthelot, Mylaine Breton, Jason Robert Guertin, et al.
Pageof 13